Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic: Influences of age and gender

Diabetes Research and Clinical Practice

Volumn 65, Issue 2, 2004, Pages 135-142

  Relimpio, F ^a   Martinez Brocca, M A ^a   Leal Cerro, A ^a   Losada, F ^a   Mangas, M A ^a   Pumar, A ^a   Astorga, R ^a  

^a Hospitales Universitarios Virgen R   (Spain)

Author keywords

Body mass index; HDL cholesterol; Hypertension; Metabolic syndrome; Microalbuminuria; Obesity; Triglycerides; Type 2 diabetes mellitus; Waist circumference; Waist to hip ratio

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC OBESITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SPAIN; URIC ACID BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; AGED; AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX CHARACTERISTICS; SPAIN;

EID: 3042660568     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.12.003     Document Type: Article

References (19)

1. Alberti K.G.M.M., Zimmet P.Z. for the WHO consultation Definition, diagnosis and classification of Diabetes Mellitus and its complications. Part 1. Diagnosis and classification of Diabetes Mellitus, provisional report of a WHO consultation. Diabet. Med. 15:1999;539-553
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
3. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults. JAMA. 287:2002;356-359
4. Barrett-Connor E., Grundy S.M., Holdbrook J.J. Plasma lipids and diabetes mellitus in an adult community. Am. J. Epidemiol. 115:1982;657-663
5. Stern M.P., Rosenthal M., Haffner S.M., Hazuda H.P., Franco L.J. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am. J. Epidemiol. 120:1984;834-851
6. Sniderman A.D., Lamarche B., Tilley J., Seccombe D., Frohlich J. Hypertriglyceridemic hyperapoB in Type 2 diabetes. Diabetes Care. 25:2002;579-582
7. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., Lee E.T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 21:1998;1258-1265
8. Goldschmid M.G., Barrett-Connor E., Edelstein S.L., Wingard D.L., Cohn B.A., Herman W.H. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation. 89:1994;991-997
9. Friedewald W.T., Levy R.J., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502
10. Balkau B., Charles M.A. for the European Group for the Study of Insulin Resistance (EGIR) Comment on the provisional report from the WHO consultation. Diabet. Med. 16:1999;442-443
11. Groop L., Ekstrand A., Forsblom C., Widen E., Groop P.H., Teppo A.M. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;642-647
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Arch. Intern. Med. 157 (1997) 2413-2446.
13. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of Hypertension: Guidelines Subcommittee, J. Hypertens. 17 (1999) 151-183.
14. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 288:2002;2709-2716
15. Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D. Lifetime risk of developing coronary heart disease. Lancet. 353:1999;89-92
16. Rossouw J.E. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc. Res. 53:2002;550-557
17. Mendelsohn M.E., Karas R.H. Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340:1999;1801-1811
18. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 316:1987;1105-1110
19. Seeman T., Mendes de Leon E., Berkman L., Ostfeld A. Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly. Am. J. Epidemiol. 138:1993;1037-1049